Literature DB >> 22266192

Proliferation rate but not mismatch repair affects the long-term response of colon carcinoma cells to 5FU treatment.

B Choudhary1, M L Hanski, M Zeitz, C Hanski.   

Abstract

The role of mismatch repair (MMR) in the response of colon carcinoma cells to 5-fluorouracil (5FU) is not well understood. In most of the in vitro studies only short-term response was investigated. We focussed here on the influence of MMR status on the mechanism of the short- and long-term response to clinically relevant 5FU concentrations by using isogenic or semiisogenic cell line pairs expressing/nonexpressing the hMLH1 protein, an important component of the MMR system. We show that the lower survival of MMR-proficient than of MMR-deficient cells in the clonogenic survival assay is due to a more frequent early cell arrest and to subsequent senescence. By contrast, the long-term cell growth after treatment, which is also affected by long-term arrest and senescence, is independent from the MMR status. The overall effect on the long-term cell growth is a cumulative result of cell proliferation rate-dependent growth inhibition, apoptosis and necrotic cell death. The main long-term cytotoxic effect of 5FU is the inhibition of growth while apoptosis and the necrotic cell death are minor contributions.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266192     DOI: 10.1016/j.canlet.2012.01.025

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Red American ginseng enhances the effect of fluorouracil on human colon cancer cells via both paraptosis and apoptosis pathways.

Authors:  Jin-Yi Wan; Haiqiang Yao; Chun-Feng Zhang; Wei-Hua Huang; Qihui Zhang; Zhi Liu; Yi Bi; Stephanie Williams; Chong-Zhi Wang; Chun-Su Yuan
Journal:  J Appl Biomed       Date:  2018-05-31       Impact factor: 1.797

2.  Paraptosis and NF-κB activation are associated with protopanaxadiol-induced cancer chemoprevention.

Authors:  Chong-Zhi Wang; Binghui Li; Xiao-Dong Wen; Zhiyu Zhang; Chunhao Yu; Tyler D Calway; Tong-Chuan He; Wei Du; Chun-Su Yuan
Journal:  BMC Complement Altern Med       Date:  2013-01-03       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.